Home/Mayne Pharma Group/Shawn Patrick O'Brien
SP

Shawn Patrick O'Brien

Former Chief Executive Officer and Managing Director

Mayne Pharma Group

Therapeutic Areas

Mayne Pharma Group Pipeline

DrugIndicationPhase
Nextstellis®Oral ContraceptionMarketed
EPSOLAY®Papulopustular RosaceaMarketed
TWYNEO®Acne VulgarisMarketed
Adelaide Apothecary PortfolioVarious Dermatological ConditionsMarketed
Generic & 505(b)(2) PipelineVarious (Women's Health, Dermatology)Development